Peerzada Abrar &Amp;Amp; Anjali Singh

Stories by Peerzada Abrar &Amp;Amp; Anjali Singh

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Rediff.com   1 Aug 2026

Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.

Why Have Flipkart, Netflix Tied Up?

Why Have Flipkart, Netflix Tied Up?

Rediff.com   1 Aug 2026

'GenZ today is close to 45 to 50 per cent of the overall shopping journeys in the country. They are also very content-first in terms of entertainment or otherwise, general gratification of content and discovery.'

Swiggy's Q1 Net Loss Shrinks 34% Amidst Strong Revenue Growth

Swiggy's Q1 Net Loss Shrinks 34% Amidst Strong Revenue Growth

Rediff.com   31 Jul 2026

Food and grocery delivery giant Swiggy has reported a significant narrowing of its net loss in the first quarter, down 34 per cent year-on-year to approximately 791 crore, while revenue from operations surged by 37 per cent to 6,812 crore. The company also achieved contribution margin break-even in its quick commerce segment, Instamart.

Anand Mahindra: M&M must enter attack mode

Anand Mahindra: M&M must enter attack mode

Rediff.com   31 Jul 2026

Mahindra Group Chairman Anand Mahindra announced the company would adopt an 'attack mode' strategy, accelerating investment, innovation, and execution to capitalise on opportunities arising from prolonged geopolitical and economic uncertainty.

L&T to invest Rs 5,000 crore in EV components, targeting Tier-I supplier status

L&T to invest Rs 5,000 crore in EV components, targeting Tier-I supplier status

Rediff.com   30 Jul 2026

Larsen & Toubro (L&T) is investing Rs 5,000 crore over five years to enter the automotive components sector, focusing on electric vehicle (EV) motors, safety systems, and connected-vehicle technologies, aiming to become a Tier-I auto supplier.

JLR India gets FTA boost, Q1 sales soar 11 percent

JLR India gets FTA boost, Q1 sales soar 11 percent

Rediff.com   29 Jul 2026

Jaguar Land Rover (JLR) India reported its highest-ever first-quarter retail sales for FY27, with 1,665 vehicles retailed, an 11 per cent year-on-year increase, largely due to sustained demand for premium SUVs and the benefits of the India-UK Free Trade Agreement.

Strong H1 Numbers May Propel Passenger Vehicles to Record 2026 Sales

Strong H1 Numbers May Propel Passenger Vehicles to Record 2026 Sales

Rediff.com   27 Jul 2026

India's passenger vehicle industry is poised for a record-breaking year in 2026, propelled by robust dispatches in the first half of the calendar year and strong demand for utility vehicles, despite facing several economic challenges.

Manipal Health to launch India's largest healthcare IPO on July 29, aiming for Rs 9,275 crore

Manipal Health to launch India's largest healthcare IPO on July 29, aiming for Rs 9,275 crore

Rediff.com   25 Jul 2026

Manipal Health Enterprises is set to launch India's largest healthcare initial public offering (IPO) on July 29, aiming to raise Rs 9,275.22 crore to fund expansion and debt reduction, with the issue closing on July 31.

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues

Rediff.com   23 Jul 2026

Dr Reddy's Laboratories reported a 68.7 per cent year-on-year decline in consolidated net profit to Rs 443.5 crore in Q1 FY27, primarily due to the end of its lenalidomide sales agreement, a Rs 240-crore provision for semaglutide API inventory quality issues, and elevated freight costs.

TVS Motor's Q1 net profit jumps 57% on record sales, robust demand across segments

TVS Motor's Q1 net profit jumps 57% on record sales, robust demand across segments

Rediff.com   22 Jul 2026

TVS Motor Company reported a significant 56.8 per cent year-on-year increase in net profit to 1,036 crore in Q1FY27, driven by record sales volumes, an improved product mix, and robust demand in both domestic and international markets, with management anticipating continued double-digit industry growth.

First Dengue Vaccine Approved for India

First Dengue Vaccine Approved for India

Rediff.com   21 Jul 2026

The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the taker has had dengue before, eliminating the need for pre-vaccination screening.

Why Is BMW Losing Profit Even After Selling More Cars?

Why Is BMW Losing Profit Even After Selling More Cars?

Rediff.com   17 Jul 2026

BMW Group India says every Re 1 depreciation in the rupee against the euro trims its profit margin by about 1 per cent, prompting the company to consider further price increases.

Google Bets Big on India's AI Future

Google Bets Big on India's AI Future

Rediff.com   15 Jul 2026

The aim is to win over the country's enterprises, developers and startups as AI systems shift from answering questions to autonomously executing tasks.

Byju Raveendran Faces Singapore Jail Sentence

Byju Raveendran Faces Singapore Jail Sentence

Rediff.com   15 Jul 2026

'The order has no practical effect unless and until he chooses to enter Singapore.'

Can Tekton SUV Bring Nissan Back Into the Big League?

Can Tekton SUV Bring Nissan Back Into the Big League?

Rediff.com   11 Jul 2026

Nissan Motor India aims to achieve a fourfold increase in domestic sales, targeting 100,000 units annually, and export another 100,000 vehicles from its Chennai plant by financial year 2027-28 (FY28), marking a significant revival of its presence in the Indian passenger vehicle market.

Tata Motors steps up its global CV ambition with Iveco

Tata Motors steps up its global CV ambition with Iveco

Rediff.com   30 Jun 2026

Tata Motors is set to acquire Italy's Iveco Group, a strategic move aimed at propelling the Indian automaker into the top four global commercial vehicle (CV) manufacturers, with projected annual revenues of $35 billion-$40 billion within five years.

Indian Pharma Bets Beyond US Generics

Indian Pharma Bets Beyond US Generics

Rediff.com   26 Jun 2026

Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios.

Heatwaves Trigger Multiple Health Risks

Heatwaves Trigger Multiple Health Risks

Rediff.com   18 Jun 2026

Health experts warn that rising temperatures could create a growing burden of silent and cumulative health stress across the population.

BMW has maxi plans for Mini Cooper, drive into Tier 2 markets

BMW has maxi plans for Mini Cooper, drive into Tier 2 markets

Rediff.com   13 Jun 2026

The luxury carmaker plans to drive growth through local assembly of the MINI Countryman, expansion into 10 new cities and a broader product portfolio.

Digital Commerce: Why Indians Lose Rs 28,000 Crore

Digital Commerce: Why Indians Lose Rs 28,000 Crore

Rediff.com   10 Jun 2026

Dark patterns are no longer just a consumer protection concern, but a broader macroeconomic challenge affecting the long-term sustainability of India's digital commerce ecosystem.